P21/ WAF1 and cyclin D1 variants and oral squamous cell carcinoma
- 29 July 2007
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 37 (3) , 151-156
Abstract
Background: Genetic factors are known to be involved in oral squamous cell carcinoma (OSCC) development. Method: We evaluated a possible association between CCND1 A870G and P21/WAF1 C98A polymorphisms and OSCC, as well as the impact of the genotypes on protein immunoexpression. The study group consisted of 80 individuals with histopathological diagnosis of OSCC and the control group consisted of 80 healthy individuals without oral lesions and matched by age, sex and tobacco usage. The genotypes were studied by the polymerase chain reaction and restriction fragment length polymorphic analysis. Paraffin‐embedded sections were used for immunohistochemical analysis. Results: No statistical association between CCND1 and/or P21/WAF1 genotypes and OSCC was demonstrated, although we found that people harbouring the combined presence of at least one variant allele of both genes showed a 1.8 times more chance of developing OSCC compared to the referent genotype. OSCC tumours from individuals with P21 heterozygous genotype showed a significantly higher immunopositivity than tumours from wild‐type individuals. Conclusion: The present study did not demonstrate a significant association between CCND1 and / or P21 / WAF1 genotypes and OSCC. However, P21 protein expression in OSCC tumours is affected by P21 / WAF1 genotype.Keywords
This publication has 28 references indexed in Scilit:
- Strong association of interleukin-4 (−590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in EuropeansOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2007
- The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancerJournal of Cancer Research and Clinical Oncology, 2007
- Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans.Oncology Reports, 2007
- Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancerOral Oncology, 2006
- Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancerOral Oncology, 2005
- Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjectsOral Oncology, 2005
- GSTM1 polymorphism and oral squamous cell carcinomaOral Oncology, 2004
- Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrationsOral Oncology, 2000
- D-type cyclinsTrends in Biochemical Sciences, 1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993